SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001047469-20-002313
Filing Date
2020-04-15
Accepted
2020-04-15 08:30:46
Documents
7
Period of Report
2020-06-02

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2241311zpre14a.htm PRE 14A 1016047
2 G106359.JPG g106359.jpg GRAPHIC 14631
3 G112243.JPG g112243.jpg GRAPHIC 7644
4 G873491.JPG g873491.jpg GRAPHIC 32234
5 G538981.JPG g538981.jpg GRAPHIC 31174
6 G153882BII001.GIF g153882bii001.gif GRAPHIC 110124
7 G153882BII002.GIF g153882bii002.gif GRAPHIC 108034
  Complete submission text file 0001047469-20-002313.txt   1436431
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-10865 | Film No.: 20792694
SIC: 2834 Pharmaceutical Preparations